Selected article for: "adjuvant chemotherapy and median survival"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_302
    Snippet: Few studies assessed outcome predictors in dogs with thyroid tumors undergoing thyroidectomy. Median survival ranged between 500‐1100 days. Larger tumors, local invasiveness and excision of both thyroid lobes negatively affected outcome, whereas adjuvant chemotherapy did not improve survival. Metastasis was not associated with a poor outcome. The aims of the present study were to calculate survival and identify prognostic factors in a large ser.....
    Document: Few studies assessed outcome predictors in dogs with thyroid tumors undergoing thyroidectomy. Median survival ranged between 500‐1100 days. Larger tumors, local invasiveness and excision of both thyroid lobes negatively affected outcome, whereas adjuvant chemotherapy did not improve survival. Metastasis was not associated with a poor outcome. The aims of the present study were to calculate survival and identify prognostic factors in a large series of dogs with thyroid tumors treated with thyroidectomy.

    Search related documents:
    Co phrase search for related documents
    • adjuvant chemotherapy and median survival: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adjuvant chemotherapy and poor outcome: 1
    • adjuvant chemotherapy and present study: 1, 2, 3, 4
    • adjuvant chemotherapy and prognostic factor: 1, 2, 3, 4, 5
    • day range and large series: 1
    • day range and large tumor: 1
    • day range and median survival: 1, 2, 3, 4
    • day range and median survival day range: 1, 2
    • day range and poor outcome: 1, 2
    • day range and present study: 1, 2, 3
    • day range and present study aim: 1
    • large series and median survival: 1
    • large series and poor outcome: 1, 2, 3
    • large series and present study: 1, 2, 3, 4, 5
    • large series and present study aim: 1, 2
    • large series and prognostic factor: 1
    • large tumor and poor outcome: 1
    • large tumor and present study: 1, 2, 3, 4
    • large tumor and present study aim: 1, 2